Free Trial

KalVista Pharmaceuticals (KALV) Short Interest Ratio & Short Volume

KalVista Pharmaceuticals logo
$10.61
+0.34 (+3.31%)
(As of 11/1/2024 ET)

KalVista Pharmaceuticals Short Interest Data

KalVista Pharmaceuticals (KALV) has a short interest of 6.81 million shares. This marks a 4.61% increase in short interest from the previous month. The short interest ratio (days to cover) is 20.1, indicating that it would take 20.1 days of the average trading volume of 482,068 shares to cover all short positions.

Current Short Interest
6,810,000 shares
Previous Short Interest
6,510,000 shares
Change Vs. Previous Month
+4.61%
Dollar Volume Sold Short
$81.58 million
Short Interest Ratio
20.1 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
43,215,000 shares
Percentage of Shares Shorted
15.76%
Today's Trading Volume
281,259 shares
Average Trading Volume
482,068 shares
Today's Volume Vs. Average
58%
Short Selling KalVista Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KALV Short Interest Over Time

KALV Days to Cover Over Time

KALV Percentage of Float Shorted Over Time

KalVista Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20246,810,000 shares $81.58 million +4.6%N/A20.1 $11.98
9/30/20246,510,000 shares $75.39 million +13.8%N/A17 $11.58
9/15/20245,720,000 shares $63.72 million +1.2%N/A15.6 $11.14
8/31/20245,650,000 shares $75.65 million -0.5%N/A17.4 $13.39
8/15/20245,680,000 shares $72.65 million -5.0%N/A17.9 $12.79
7/31/20245,980,000 shares $86.95 million -5.5%N/A18.3 $14.54
7/15/20246,330,000 shares $94.70 million +7.7%N/A18.4 $14.96
6/30/20245,880,000 shares $69.27 million +4.3%N/A17.7 $11.78
6/15/20245,640,000 shares $68.07 million +2.2%N/A15.4 $12.07
5/31/20245,520,000 shares $64.42 million -4.2%N/A14.1 $11.67
5/15/20245,760,000 shares $69.18 million +4.0%N/A11.7 $12.01
4/30/20245,540,000 shares $62.88 million -4.8%N/A7.4 $11.35
4/15/20245,820,000 shares $68.33 million +5.4%N/A7.3 $11.74
3/31/20245,520,000 shares $65.47 million +12.2%N/A6.8 $11.86
3/15/20244,920,000 shares $58.70 million +9.1%N/A6.4 $11.93
2/29/20244,510,000 shares $61.56 million +50.8%18.6%5.9 $13.65
2/15/20242,990,000 shares $44.13 million +21.1%12.4%4.4 $14.76
1/31/20242,470,000 shares $38.95 million -10.5%12.9%6.1 $15.77
1/15/20242,760,000 shares $35.77 million -25.2%14.2%8.3 $12.96
12/31/20233,690,000 shares $45.20 million +5.7%18.7%11.8 $12.25
12/15/20233,490,000 shares $37.27 million -9.6%16.7%10.8 $10.68
11/30/20233,860,000 shares $32.58 million -3.5%18.2%13.4 $8.44
11/15/20234,000,000 shares $30.76 million -3.4%19.0%13.9 $7.69
10/31/20234,140,000 shares $35.15 million -10.8%17.3%14.8 $8.49
10/15/20234,640,000 shares $42.13 million +4.7%N/A16.9 $9.08
9/30/20234,430,000 shares $42.66 million +9.1%N/A16.9 $9.63
9/15/20234,060,000 shares $39.87 million +4.6%N/A19.4 $9.82
8/31/20233,880,000 shares $42.10 million -5.4%N/A19.1 $10.85
8/15/20234,100,000 shares $44.32 million +2.8%19.7%21.4 $10.81
7/31/20233,990,000 shares $40.30 million +2.3%18.3%21 $10.10
7/15/20233,900,000 shares $37.60 million +3.7%17.9%21 $9.64
6/30/20233,760,000 shares $33.84 million +0.8%17.3%18.5 $9.00
6/15/20233,730,000 shares $35.92 million +3.9%17.2%17.2 $9.63
5/31/20233,590,000 shares $35.00 million +5.0%16.5%14.6 $9.75
5/15/20233,420,000 shares $34.58 million +4.3%15.8%12.6 $10.11
4/30/20233,280,000 shares $27.98 million +17.1%14.0%11.5 $8.53
4/15/20232,800,000 shares $22.15 million +3.3%12.0%8.7 $7.91
3/31/20232,710,000 shares $21.30 million +10.2%11.6%8 $7.86
3/15/20232,460,000 shares $18.33 million +13.4%N/A7 $7.45
2/28/20232,170,000 shares $15.91 million -19.6%N/A6.3 $7.33
Crypto Crash Ahead? (27 Experts Weigh In) (Ad)

Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!

Click here to reserve your spot at the emergency crypto summit now.
2/15/20232,700,000 shares $20.87 million -0.4%N/A8.6 $7.73
1/31/20232,710,000 shares $21.57 million +26.6%N/A8.9 $7.96
1/15/20232,140,000 shares $15.19 million -10.5%N/A6.7 $7.10
12/30/20222,390,000 shares $16.16 million +14.9%10.2%7.4 $6.76
12/15/20222,080,000 shares $11.90 million No Change10.4%4.7 $5.72
11/30/20222,080,000 shares $11.21 million No Change10.4%5.1 $5.39
11/15/20222,080,000 shares $10.86 million -8.8%10.4%5.1 $5.22
10/31/20222,280,000 shares $11.56 million -0.4%10.9%5.5 $5.07
10/15/20222,290,000 shares $10.44 million -10.2%10.9%6.2 $4.56
9/30/20222,550,000 shares $37.00 million +3.7%12.2%7.7 $14.51
9/15/20222,460,000 shares $36.43 million +4.7%11.8%13.2 $14.81
8/31/20222,350,000 shares $38.70 million +14.6%11.2%10.7 $16.47
8/15/20222,050,000 shares $32.41 million +8.5%9.8%7.3 $15.81
7/31/20221,890,000 shares $23.34 million +2.7%9.0%6.1 $12.35
7/15/20221,840,000 shares $22.69 million +3.4%8.7%5.7 $12.33
6/30/20221,780,000 shares $17.52 million -16.8%8.5%5.3 $9.84
6/15/20222,140,000 shares $19.07 million +58.5%10.2%6.4 $8.91
5/31/20221,350,000 shares $12.00 million +7.1%6.4%4.6 $8.89
5/15/20221,260,000 shares $12.23 million +37.7%6.0%5.4 $9.71
4/30/2022914,800 shares $11.65 million +4.6%4.3%4.4 $12.73
4/15/2022874,800 shares $12.56 million -19.7%4.2%4.2 $14.36
3/31/20221,090,000 shares $16.07 million -17.4%5.2%5.2 $14.74
3/15/20221,320,000 shares $19.14 million +1.5%6.3%6.6 $14.50
2/28/20221,300,000 shares $20.87 million +13.0%6.2%6.3 $16.05
2/15/20221,150,000 shares $18.95 million -5.7%5.5%5 $16.48
1/31/20221,220,000 shares $15.40 million +15.1%5.8%5.7 $12.62
1/15/20221,060,000 shares $13.29 million +11.9%5.0%5 $12.54
12/31/2021947,400 shares $12.53 million +0.4%4.5%4.7 $13.23
12/15/2021943,800 shares $12.81 million -2.2%4.2%4.4 $13.57
11/30/2021964,800 shares $13.99 million -6.3%4.3%4.4 $14.50
11/15/20211,030,000 shares $17.94 million -5.5%4.6%5.4 $17.42
10/29/20211,090,000 shares $19.60 million -11.4%4.9%5.8 $17.98
10/15/20211,230,000 shares $21.17 million +3.4%5.5%6.9 $17.21
9/30/20211,190,000 shares $20.77 million -14.4%5.4%6.5 $17.45
9/15/20211,390,000 shares $26.76 million -21.0%6.2%7 $19.25
8/31/20211,760,000 shares $35.97 million -4.9%7.9%8.7 $20.44
8/13/20211,850,000 shares $35.72 million -4.2%8.3%8.6 $19.31
7/30/20211,930,000 shares $38.87 million -1.5%9.5%8.5 $20.14
7/15/20211,960,000 shares $43.04 million -2.0%9.9%7.7 $21.96
6/30/20212,000,000 shares $47.92 million +39.9%10.1%6.7 $23.96
6/15/20211,430,000 shares $40.78 million +3.6%7.2%4.6 $28.52
5/28/20211,380,000 shares $37.26 million -3.5%7.0%4.2 $27.00
5/14/20211,430,000 shares $35.91 million +6.7%N/A3.9 $25.11
4/30/20211,340,000 shares $33.81 million +3.1%N/A1.2 $25.23
4/15/20211,300,000 shares $32.40 million +10.2%N/A1.2 $24.92
3/31/20211,180,000 shares $30.33 million +51.8%N/A1.2 $25.70
3/15/2021777,400 shares $25.27 million -0.6%N/A0.8 $32.50
2/26/2021782,400 shares $25.99 million +22.0%N/A0.9 $33.22
2/12/2021641,100 shares $25.93 million +25.0%3.8%0.7 $40.45
1/29/2021513,100 shares $8.02 million +28.2%4.5%0.8 $15.64
Crypto Crash Ahead? (27 Experts Weigh In) (Ad)

Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!

Click here to reserve your spot at the emergency crypto summit now.
1/15/2021400,200 shares $6.88 million +4.7%3.5%3.3 $17.18
12/31/2020382,400 shares $7.22 million +27.3%3.4%3.2 $18.89
12/15/2020300,300 shares $5.69 million -11.6%2.7%3 $18.95
11/30/2020339,700 shares $6.61 million +3.9%3.0%3.8 $19.47
11/15/2020326,900 shares $6.15 million +47.0%2.8%3.8 $18.80
10/30/2020222,400 shares $3.83 million -12.3%1.9%2.9 $17.22
10/15/2020253,600 shares $3.79 million +2.3%2.2%3.7 $14.95
9/30/2020247,900 shares $3.12 million -16.4%2.1%3.8 $12.59
9/15/2020296,600 shares $4.12 million -7.1%2.5%3.4 $13.88
8/31/2020319,100 shares $4.18 million -10.6%2.7%2.6 $13.10
8/14/2020356,900 shares $4.53 million -9.2%2.8%2.8 $12.70
7/31/2020392,900 shares $3.86 million -8.7%3.1%2.9 $9.83
7/15/2020430,200 shares $4.97 million +9.8%3.4%3.2 $11.56
6/30/2020391,800 shares $4.74 million +24.2%3.1%2.8 $12.10
6/15/2020315,500 shares $3.28 million -7.5%2.5%2.3 $10.40
5/29/2020341,200 shares $3.71 million +1.2%2.7%2.6 $10.86
5/15/2020337,200 shares $3.42 million -2.7%2.7%2.3 $10.15
4/30/2020346,600 shares $4.10 million -3.5%2.8%2.5 $11.82
4/15/2020359,200 shares $3.70 million -10.6%2.9%2.6 $10.30
3/31/2020401,600 shares $4.47 million -33.9%3.2%2.8 $11.14
3/13/2020607,100 shares $5.77 million -2.5%4.8%3.1 $9.51
2/28/2020622,600 shares $4.40 million +0.8%4.9%4.6 $7.06
2/14/2020617,500 shares $6.42 million -11.9%4.9%4.6 $10.40
1/31/2020700,600 shares $9.64 million -3.5%5.6%5.2 $13.76
1/15/2020725,700 shares $11.05 million -17.3%5.8%5.3 $15.23
12/31/2019877,600 shares $14.99 million +11.3%7.0%6.2 $17.08

KALV Short Interest - Frequently Asked Questions

What is KalVista Pharmaceuticals' current short interest?

Short interest is the volume of KalVista Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 6,810,000 shares of KALV short. Learn More on KalVista Pharmaceuticals' current short interest.

What is a good short interest ratio for KalVista Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KALV shares currently have a short interest ratio of 20.0. Learn More on KalVista Pharmaceuticals's short interest ratio.

Is KalVista Pharmaceuticals' short interest increasing or decreasing?

KalVista Pharmaceuticals saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 6,810,000 shares, an increase of 4.6% from the previous total of 6,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does KalVista Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to KalVista Pharmaceuticals: Alimera Sciences, Inc. (1.10%), Arbutus Biopharma Co. (4.13%), BeyondSpring Inc. (8.42%), BioCryst Pharmaceuticals, Inc. (10.89%), Recursion Pharmaceuticals, Inc. (26.21%), Arvinas, Inc. (13.58%), Mirum Pharmaceuticals, Inc. (14.67%), Galapagos NV (2.36%), Tectonic Therapeutic (4.28%), Wave Life Sciences Ltd. (3.92%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short KalVista Pharmaceuticals stock?

Short selling KALV is an investing strategy that aims to generate trading profit from KalVista Pharmaceuticals as its price is falling. KALV shares are trading up $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against KalVista Pharmaceuticals?

A short squeeze for KalVista Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KALV, which in turn drives the price of the stock up even further.

How often is KalVista Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALV, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:KALV) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners